<?xml version="1.0" encoding="UTF-8"?>
<html xmlns:fo="http://www.w3.org/1999/XSL/Format"
	xmlns:xi="http://www.w3.org/2001/XInclude">
<head>
<meta xmlns="http://www.w3.org/1999/xhtml" http-equiv="Content-Type"
	content="text/html; charset=utf-8" />
<style type="text/css">
@media screen {
	.test-story-main legend {
		text-align: center;
		font-size: 110%;
		font-weight: bold;
	}
	.test-story-main .nav-tabs {
		font-weight: bold;
	}
	.test-story-main .tds_obxGrpSpl {
		background: #B8B8B8;
	}
	.test-story-main maskByMediaType {
		display: table;
	}
	.test-story-main table tbody tr th {
		font-size: 95%
	}
	.test-story-main table tbody tr td {
		font-size: 110%;
	}
	.test-story-main table tbody tr th {
		text-align: left;
		background: #C6DEFF;
		font-size: 100%;
	}
	.test-story-main fieldset {
		text-align: center;
	}
	.test-story-main table {
		width: 98%;
		border: 1px groove;
		table-layout: fixed;
		margin: 0 auto;
		border-collapse: collapse;
	}
	.test-story-main table tr {
		border: 2px groove;
	}
	.test-story-main table th {
		border: 2px groove;
	}
	.test-story-main table td {
		border: 1px groove;
	}
	.test-story-main table thead {
		border: 1px groove;
		background: #446BEC;
		text-align: center;
	}
	.test-story-main .separator {
		background: rgb(240, 240, 255);
		text-align: left;
	}
	.test-story-main table tbody tr td {
		text-align: left
	}
	.test-story-main .noData {
		background: #B8B8B8;
	}
	.test-story-main .childField {
		background: #B8B8B8;
	}
	.test-story-main .title {
		text-align: left;
	}
	.test-story-main h3 {
		text-align: center;
		page-break-inside: avoid;
	}
	.test-story-main h2 {
		text-align: center;
	}
	.test-story-main h1 {
		text-align: center;
	}
	.test-story-main .pgBrk {
		padding-top: 15px;
	}
	.test-story-main .er7Msg {
		width: 100%;
	}
	.test-story-main .embSpace {
		padding-left: 15px;
	}
	.test-story-main .accordion-heading {
		font-weight: bold;
		font-size: 90%;
	}
	.test-story-main .accordion-heading i.fa:after {
		content: "\00a0 ";
	}
	.test-story-main panel {
		margin: 10px 5px 5px 5px;
	}
}

@media print {
	.test-story-main legend {
		text-align: center;
		font-size: 110%;
		font-weight: bold;
	}
	.test-story-main .nav-tabs {
		font-weight: bold;
	}
	.test-story-main .obxGrpSpl {
		background: #B8B8B8;
	}
	.test-story-main maskByMediaType {
		display: table;
	}
	.test-story-main table tbody tr th {
		font-size: 90%
	}
	.test-story-main table tbody tr td {
		font-size: 90%;
	}
	.test-story-main table tbody tr th {
		text-align: left;
		background: #C6DEFF;
	}
	.test-story-main table thead tr th {
		text-align: center;
		background: #4682B4;
	}
	.test-story-main fieldset {
		text-align: center;
		page-break-inside: avoid;
	}
	.test-story-main table {
		width: 98%;
		border: 1px groove;
		table-layout: fixed;
		margin: 0 auto;
		page-break-inside: avoid;
		border-collapse: collapse;
	}
	.test-story-main table tr {
		border: 2px groove;
	}
	.test-story-main table th {
		border: 2px groove;
	}
	.test-story-main table td {
		border: 1px groove;
	}
	.test-story-main table thead {
		border: 1px groove;
		background: #446BEC;
		text-align: left;
	}
	.test-story-main .separator {
		background: rgb(240, 240, 255);
		text-align: left;
	}
	.test-story-main table tbody tr td {
		text-align: left;
	}
	.test-story-main .noData {
		background: #B8B8B8;
	}
	.test-story-main .childField {
		background: #B8B8B8;
	}
	.test-story-main .tds_title {
		text-align: left;
		margin-bottom: 1%
	}
	.test-story-main h3 {
		text-align: center;
	}
	.test-story-main h2 {
		text-align: center;
	}
	.test-story-main h1 {
		text-align: center;
	}
	.test-story-main .tds_pgBrk {
		page-break-after: always;
	}
	.test-story-main #er7Message table {
		border: 0px;
		width: 80%
	}
	.test-story-main #er7Message td {
		background: #B8B8B8;
		font-size: 65%;
		margin-top: 6.0pt;
		border: 0px;
		text-wrap: preserve-breaks;
		white-space: pre;
	}
	.test-story-main .er7Msg {
		width: 100%;
		font-size: 80%;
	}
	.test-story-main .er7MsgNote {
		width: 100%;
		font-style: italic;
		font-size: 80%;
	}
	.test-story-main .embSpace {
		padding-left: 15px;
	}
	.test-story-main .embSubSpace {
		padding-left: 25px;
	}
	.test-story-main .accordion-heading {
		font-weight: bold;
		font-size: 90%;
	}
	.test-story-main .accordion-heading i.fa:after {
		content: "\00a0 ";
	}
	.test-story-main panel {
		margin: 10px 5px 5px 5px;
	}
}
</style>
</head>
<body>
	<!-- generated by TestStory_v1.xslt Version:1.0   Profile:TestStory-->
	<fieldset>
		<div class="test-story-main">
			<table><tr><th>Description</th></tr><tr><td><p>This provides the details for vaccine products that should exist in the system under test before testing scenarios are performed.</p><p>This IIP test plan tests clients with NDC as the primary code set and CVX as an alternate code set. Please note that this configuration may vary among jurisdictions. NDC is required for all new administrations and CVX for historical but can include NDC if known.<br><br></p></td></tr></table><br/><table><tr><th>Data Entry</th></tr><tr><td><p><strong>Inventory</strong></p><table border="0" cellpadding="0" cellspacing="0" width="252"><tbody><tr height="21"><td height="21" width="252"><strong>Item 1</strong></td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td width="260">PEDIARIX 58160-0811-43</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>58160-0811-52</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>58160-0811-43</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>DTaP-Hep B-IPV</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>GlaxoSmithKline</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN01</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Public</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>110</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>SKB</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>VXC50</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>10 pack &ndash; 1 dose syringe</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>PEDIARIX</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 65px; height: 65px;"><br></td></tr><tr height="21"><td height="21" width="252">GTIN</td><td>10358160811439</td></tr><tr height="21"><td height="21" width="252"><br></td><td>(01)10358160811439(17)290927(10)IIPVAXN01</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 2</strong></td><td width="260"><br></td></tr><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td>RECOMBIVAX HB 00006-4981-01</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>00006-4981-00</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>00006-4981-01</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>Hep B, adolescent or pediatric</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>Merck and Co., Inc.</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN02</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Public</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>08</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>MSD</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>VXC50</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>10 pack &ndash; 1 dose vial</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>RECOMBIVAX HB</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 74px; height: 74px;"><br></td></tr><tr height="29"><td height="29" width="252">GTIN</td><td>00300064981018</td></tr><tr height="21"><td height="21" width="252"><br></td><td>(01)00300064981018(17)290927(10)IIPVAXN02</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 3</strong></td><td width="260"><br></td></tr><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td>ENGERIX-B 58160-0821-05</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>58160-0821-34</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>58160-0821-05</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>Hep B, adult</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>GlaxoSmithKline</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN03</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Private funds</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>43</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>SKB</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>PHC70</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>Unknown</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>ENGERIX-B</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 68px; height: 68px;"><br></td></tr><tr height="21"><td height="21" width="252">GTIN</td><td>10358160821056</td></tr><tr height="21"><td height="21" width="252"><br></td><td>(01)10358160821056(17)290927(10)IIPVAXN03</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 4</strong></td><td width="260"><br></td></tr><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td>ENGERIX-B 58160-0820-43</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>58160-0820-52</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>58160-0820-43</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>Hep B, adolescent or pediatric</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>GlaxoSmithKline</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN04</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Public</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>08</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>SKB</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>VXC50</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>10 pack &ndash; 1 dose syringe</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>ENGERIX-B</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 68px; height: 68px;"><br></td></tr><tr height="17"><td height="17" width="252">GTIN</td><td>10358160820431</td></tr><tr height="21"><td height="21" width="252"><br></td><td>(01)10358160820431(17)290927(10)IIPVAXN04</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 5</strong></td><td width="260"><br></td></tr><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td>ActHIB 49281-0547-58</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>49281-0545-03</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>49281-0547-58</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>Hib (PRP-T)</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>sanofi pasteur</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN05</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Public</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>5</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>48</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>PMC</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>VXC50</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>5 pack &ndash; 1 dose vial</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>ActHIB</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 72px; height: 72px;"><br></td></tr><tr height="21"><td height="21" width="252">GTIN</td><td>00349281547584</td></tr><tr height="18"><td height="18" width="252"><br></td><td>(01)00349281547584(17)290927(10)IIPVAXN05</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 6</strong></td><td width="260"><br></td></tr><tr height="42"><td height="42" width="252">Product Name (This may vary with each implementation)</td><td>Prevnar 20 00005-2000-01</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>00005-2000-10</td></tr><tr height="21"><td height="21" width="252"><strong>Unit-of-Use (Syringe or Vial) NDC</strong></td><td><strong>00005-2000-01</strong></td></tr><tr height="60"><td height="60" width="252">Generic Name (CVX 216)</td><td width="260">Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>Pfizer, Inc</td></tr><tr height="20"><td height="20">Lot Number</td><td>LLBUAYMO6</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Public</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>216</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>PFR</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>VXC50</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>10 pack &ndash; 1 dose syringe</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>Prevnar 20</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 7</strong></td><td width="260"><br></td></tr><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td>Rotarix 58160-0740-02</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>58160-0740-21</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>58160-0740-02</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>rotavirus, monovalent</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>GlaxoSmithKline</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN07</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Public</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>119</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>SKB</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>VXC50</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>10 pack &ndash; 1 oral dose</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>Rotarix</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 69px; height: 69px;"><br></td></tr><tr height="40"><td height="40" width="252">GTIN</td><td>10358160740029</td></tr><tr height="21"><td height="21" width="252"><br></td><td>(01)10358160740029(17)290927(10)IIPVAXN07</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 8</strong></td><td width="260"><br></td></tr><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td>GARDASIL 9 00006-4121-01</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>00006-4121-02</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>00006-4121-01</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>HPV9</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>Merck and Co., Inc.</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN08</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Private funds</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>165</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>MSD</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>PHC70</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>10 pack &ndash; 1 dose syringe</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>GARDASIL 9</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAH0AAAB9CAMAAAC4XpwXAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAHyUExURQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAALnXpggAAACldFJOUwABAgMEBgcICgsMDRAREhMUFRYaHiIjJCUnKCkrLC0vMDEyMzQ1Njc4OTo/QEFERUZJSk1QUVJTVFVWV1haXF1eZGVmZ2huc3R1dnd4eXp7fH1+f4CBgoSFhoeIiYqLjJGXmJmam6Gio6WnqKmqq6ytrq+ytba5uru/wMXGx8jJysvMzc7P0NLT1NbX2Nrb3N3h5enq6+zt7u/y8/T19/j5+/z9/plPvxgAAAAJcEhZcwAAFxEAABcRAcom8z8AAAtQSURBVGhD7Ztrl1XFEYYREY0gIEqiiEqEeIOgURAFFTBeAlGTOJNEEokXBFSQy6gR8BYwqIgX5CoYRET+Z6x66izqXbt69gxZWXzx+bS7q3e/c/ac3d1vV58J54yjyycYQ17YPMOu5+/5/wcm/KR+dJlfE9nS09deuz4mgel2Pa8IjH5HqB++x6+JvDnTrpvqt39h198vSYEdl9r17AN2fXZlChR3rPbAxoleQP34qhnG0FFjwzSrb6rP3WmNPl+R7th0nV0v3GXXny0e/Y7nPDByvRdQP/3OZmN4uXHnZLulqT7tbmu08vl0xxMb7frFx+x68bWj3/GJB74a8QLqwbDfCKN8VYzJ272KO+47bdf753gBmncIF6o+ZatXccf9J+36o5u9AM07hAtVn7HZq7hj+VG73jPfC9C8QxD1v0VDQ9TXeviNq73gXP2GV6F+7xG7fn+2FwD1Vy6L4o/0qv85GhqiPuxhBgKYscWrUF/GZ5/nBYjPHq+10VY/tW3Y+HU0NER9oYcfuMILzhUPeNXwkPH6KWt7aL1dr+a7h/onz1nVI9dYTajv5j5APca6jKg3QSQjQxrs9S9EqA95eIBXHbk3Sue5UPXvHu4EDtxmNaH+lIcHeFUhcqHqcUcO8DKEen6v2uo3f2SBbx6KYoOuetyRAx/cZDXxvv/VwwO8qlCfs98C8RybdNWLJ8+rGGPd3z08wKtCfY6Nx8FjL9pAvOEOD8C1iy1wt09Ck+/0VkM+XL/jI+3xf6Y7svrBp61pjPP3e5iulov6apuLgl0LbRKa7jNOsPgzC+yca9fTNnirYZ+qVh23TvYtSndk9TMnrGnMcby1dHVU1Jn94EAeuWDlWQt8cbtdz3zTW/EduuewXb/3Cy9A918S8zvQVYw2oZ5v2ZtHLlh+zAN8g8c01mViIAC6Gqjz3/iTF0DmDHjwhAX+/Su7lveHwIe3eAG66l/nEW3Z116H+uHfeN3vvACF+sofLPClP3lRJyD/q676WRY9sDg/+RNPzTfWewFQnzTLAz5QT7hr554f2XSDXYs6gW1LrelcfyVC/fg+C8DuR70reHS316F+5qAXDnkBUJ+61gO/9R6nzbUbb/iZXYs6gaXbrOnOu7wK9bcXWQAWvORdwUsLvA71AtRnvuWFf3iPmWLcZE37Q17TbrzEC87EEa+CkbymLUB9BsPjX7xpplC/5UOrOfGgF1B/baoXnKt4S2DLVVRGsYNMi1kEpncDMi+hnlcXcQeImyhgUGmqT9zYCRTqA9NgXLrDqwD/EepnT/rAl2FALdQnTbUB83r+iz3qYRqc6zZFzwb+I9zEyRd80M8wmRTqs561yWLkq06gUA/T4Gx8Ino28B/hJoq1DRTqt/lXO+hRz5y+zwOA/4jR5kieATKF+q0fexWMQ/0kozngP3SW6VKoIxKMQ1008B996mIaYPb7XgV5jSirIfxH5lt58t96Xd9nzxMpzMufPa+PZfcA/5EZZYbNkTmrz1sAMQ2wPs8Gu6LS8ZZrbvRO8B/bsBkveyFagdcM3ET372KsC7r/xYJiPZKXHe2xTtQf/s6qsADBmNTFv0O2l5dn/779co9Xn73lh3uQOyB3Fa8PDKy1F0R9if/B0tcfvFUPmAaBrghc+aq3gq1TPF6o87hE/ffeqgfx75Cf/GWveCvYHit1L4Q6buIFH4dQD9OQNz0wDTHOZzANAl0RWPWut9rvA/zzKz0u6riJk77iQz1Mg784AaYh5rgMpkGgKwLHGNrX+eS24nOPi3p2E6iHachgGmJ+Hz9r7O4JS773gqjnrzbqMdZlird3PDBsVm4iq+MNZDEGzcDYYImI/wj1cBNZHW8gC1FoBsYGy2P8R6iHmxiK1baBN5BFOEiAMR/T8Ol/vJDJbiLAGuA/1E0MW78B3kAMCEgA94NpWPGpFzLZTQTYIvyHugmZxtnvzuYLJIDzwzT8/D0vZLKbKIl2TlbHG4jxBAngejENv/yXFzLZTZREOyerxzqpq16lIHy+JCBkN1ES7ZyueiQtMpKCYHzKuQkhu4mSaOd01SNpwWbL5Ol2LSkIxuacmwgYm7ObCHJX4SaCrnokLRiM7thg15KCYF7KuYmAeSm7iSB31ZebCNhkY9FTLGGK3ERzTs5dxWgTNNXZYHzoG7uWFAQUuYnmeiR3NUZ1AsWSC8azFstdjUu9WPQA3kCe/JNWU0H+Y1xPnkCsj4vPzho8r6ifsZoK8h8yw0ZuggX/Un8pUJcAKQhRX+CB8AZcwy5rem7/OiIJ8h83rvEC6u08bA6AqGOY/sexLvw7IqSeUJcAiDpmEW+AixRyTqrEW8nKipV+fPbWkivo3iHkfFyJt4rdA/rakT57oV681k11uhoFb9V88oV6MaQ11XP+sMRbxa4RmYbH3eUU6ozaxXBeqGMa6IocdIDBltxE7JiRaZji02KhzoxVTGWFOqaBrsi/B6znJTcRdEcbUWe2LqbxQh0R4OxBsM6rJDcR9Ki3X+uuunSV7yAgY12Qb2nu+RIQisAzVhNIAA3JTQRZnQdc7HdXC6huID95CaAhuYmASM9eP4EAN5ED+zw7du5lqwnkDjyD5CYC1HvyHAQC3EQOLHrbqw5ZTSB34Jeq3ATqPTkeCeQ8EoFLuta66KrKTaDek9+SQM6hEZj6WhTPU3RV5SZQL9YKWb2YZUCyGZlRjkR4IUCdfQV5XBxPAlHPux2SzcgUKVI56SQjLXsqZIGD7pZKkPPGks045VXs2xTpYTnpJLMM+0lkwAOOJ4Go55y5ZDO2ehV7VkVqXE46yQzLXlqxUgFR7xLqT3qBVTAUxwJitJHVBfuInHwoGJv6H73AXiUURyJCXSeT1loBxqYerw+mwRGNQJ48FqBHvfBxmdiKxjRk9chNiM2Iz87CGQvQo15sw2diIy9MQ1KP/QaxGaifej1ZgKZ6eANvGgeagGxG4G3CNKAuuQmxGagLTfW8uqiyLI4G8F7d3c1qrIOmOt6gOIgTntCR1BPqRW5iYDOimGh/9hSIbzDkf28R4C2JlwHoqq0uKUfINkOyl5FZdCTlmNMcoi65CQF1SbdCYfAgsqqOpFuz4xd1yU0IqJNqFrLNkKx1ZJQdSTXnNEeoF7kJAXXS7EK2GZKxj2y6I2n2nOYI9SI3IQy+EQ1QFwYnCQw5YgCiXuQmhPGr502CImkh6nn9VKkP1lwNCjexNf298uUCORuFzajcBAzWmw0KN/GWnzqHQl3ORoWLLNwEi/BYa2fylr6YBu5YmzbCRZ2FvpyNwmZUbkIimZzOENPAHbMmedwRdUyOnI2STyjq8lQyOZUjpiHbNRD1nJuQQOUm5BuRyWksMQ3ZqoKI5NyEBPrchCA2o/v+ZCR/2HwV224i9hUyBBgieo5ASe405yYkdyonnQL6ij2VTLYZxREoMg1TJ9m15I1zbiLyxtgMOekU0FfsJ2WyzSiOQJFpeHaWXUvOPOcmImeOzZCTTkH3OQYsgwfToiHqxUmNZm4CmyEnnYIe9cGSwBB1Mg0f3+oFaOYmsBly0inoUc/Tj6jnBVQgpiGT71D1/LsJoaseR6CyaZBzFz3qctIpyL+bEIrPzmudTUPPWeIgPnueYYvfTVzziK395VcQWT2OQIlp8N9NDPCwnHQKUniU301k09BVF+K/mOEj9v6YxAuyQgXWtGK6x6+ez9sEdNU+6QQsoAprXdBUjy9E92UYdOWF4mTjTR+kAG/vq1d6oUveJAjy7oEcgdKuvFA8eY4QRoCRq5njyRskQd45kSevXXmhONH69MEUYNR+d5UXumAahLxrJEegpCvUi9O8J86kADPW6WNe6IJpEPKOmRyBkq5Qv1j8pH6xuJjq5879F9BZdkcBzaIzAAAAAElFTkSuQmCC" alt="" class="fr-dii fr-draggable" style="width: 73px; height: 73px;"><br></td></tr><tr height="23"><td height="23" width="252">GTIN</td><td>00300064121018</td></tr><tr height="21"><td height="21" width="252"><br></td><td>(01)00300064121018(17)290927(10)IIPVAXN08</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 9</strong></td><td width="260"><br></td></tr><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td>GARDASIL 9 00006-4121-01</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>00006-4121-02</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>00006-4121-01</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>HPV9</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>Merck and Co., Inc.</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN09</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>3/26/2024</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Public</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>165</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>MSD</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>VXC50</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>10 pack &ndash; 1 dose syringe</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>GARDASIL 9</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 69px; height: 69px;"><br></td></tr><tr height="20"><td height="20" width="252">GTIN</td><td>00300064121018</td></tr><tr height="21"><td height="21" width="252"><br></td><td>(01)00300064121018(17)240326(10)IIPVAXN09</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 10</strong></td><td width="260"><br></td></tr><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td>PEDIARIX 58160-0811-43</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>58160-0811-52</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>58160-0811-43</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>DTaP-Hep B-IPV</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>GlaxoSmithKline</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN10</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Private funds</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>110</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>SKB</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>PHC70</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>10 pack &ndash; 1 dose syringe</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>PEDIARIX</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 74px; height: 74px;"><br></td></tr><tr height="21"><td height="21" width="252">GTIN</td><td>10358160811439</td></tr><tr height="21"><td height="21" width="252"><br></td><td>(01)10358160811439(17)290927(10)IIPVAXN10</td></tr></tbody></table><p><br></p><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="21"><td height="21" width="252"><strong>Item 11</strong></td><td width="260"><br></td></tr><tr height="43"><td height="43" width="252">Product Name (This may vary with each implementation)</td><td>HAVRIX 58160-0825-43</td></tr><tr height="21"><td height="21" width="252">Unit-of-Sale (Box) NDC</td><td>58160-0825-52</td></tr><tr height="21"><td height="21" width="252">Unit-of-Use (Syringe or Vial) NDC</td><td>58160-0825-43</td></tr><tr height="21"><td height="21" width="252">Generic Name</td><td>Hep A, ped/adol, 2 dose</td></tr><tr height="21"><td height="21" width="252">Manufacturer</td><td>GlaxoSmithKline</td></tr><tr height="20"><td height="20">Lot Number</td><td>IIPVAXN11</td></tr><tr height="21"><td height="21" width="252">Expiration Date</td><td>9/27/2029</td></tr><tr height="21"><td height="21" width="252">Funding Source</td><td>Private funds</td></tr><tr height="21"><td height="21" width="252">Doses on Hand</td><td>10</td></tr><tr height="21"><td height="21" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">&nbsp;</td><td><br></td></tr><tr height="20"><td height="20">CVX Code</td><td>83</td></tr><tr height="21"><td height="21" width="252">MVX Code</td><td>SKB</td></tr><tr height="22"><td height="22" width="252"><br></td><td><br></td></tr><tr height="21"><td height="21" width="252">Funding Source Code</td><td>PHC70</td></tr><tr height="21"><td height="21" width="252">Packaging</td><td>10 pack &ndash; 1 dose syringe</td></tr><tr height="21"><td height="21" width="252">Trade Name</td><td>HAVRIX</td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0" width="512"><tbody><tr height="97"><td height="97" width="252">Unit-of-Use (Vial/Syringe) Image</td><td width="260"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 71px; height: 71px;"><br></td></tr><tr height="21"><td height="21" width="252"><br></td><td>(01)10358160825436(17)290927(10)IIPVAXN11</td></tr><tr height="21"><td height="21" width="252">GTIN</td><td>10358160825436</td></tr></tbody></table></td></tr></table><br/><table><tr><th>Post-Condition</th></tr><tr><td><p>Data listed in the test cases listed below exist in the system under test.</p><p><br></p></td></tr></table><br/><table><tr><th>Notes</th></tr><tr><td><p>This activity is not performed under proctor observation.</p><p>If unable to enter expired vaccination product please alert the proctor.</p><p>This was an attestation item-previously attested to.</p><p><br><strong>Jurisdictions will individually determine if the Unit of Use or Unit of Sale NDC will be used when submitting vaccines to their IIS. This plan uses the Unit of Use NDC.</strong><br><br></p></td></tr></table><br/>
		</div>
	</fieldset>
</body>
</html>